My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 175

    1.

    The proline 12 alanine substitution in the peroxisome proliferator--activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo.

    Schneider J, Kreuzer J, Hamann A, Nawroth PP, Dugi KA.

    Diabetes. 2002 Mar;51(3):867-70.PMID: 11872694 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.

    Kolehmainen M, Uusitupa MI, Alhava E, Laakso M, Vidal H.

    J Clin Endocrinol Metab. 2003 Apr;88(4):1717-22.PMID: 12679463 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus]

    Fu M, Chen H, Li X, Li J, Wu B, Cheng L, Cai M, Fu Z.

    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8. Chinese. PMID: 12048686 [PubMed - indexed for MEDLINE]Related articles

    4.

    Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression.

    Sartippour MR, Renier G.

    Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):104-10.PMID: 10634806 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase.

    Ziouzenkova O, Perrey S, Asatryan L, Hwang J, MacNaul KL, Moller DE, Rader DJ, Sevanian A, Zechner R, Hoefler G, Plutzky J.

    Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2730-5. Epub 2003 Feb 26.PMID: 12606719 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease.

    Duman BS, Türkoğlu C, Akpinar B, Güden M, Vertii A, Dak E, Cağatay P, Günay D, Büyükdevrim AS.

    Arch Pathol Lab Med. 2004 Aug;128(8):869-74.PMID: 15270617 [PubMed - indexed for MEDLINE]Related articles

    7.

    Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.

    Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E; Berlin Diabetes Mellitus (BeDiaM) Study.

    Diabetes. 2002 Aug;51(8):2653-7.PMID: 12145184 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator--activated receptor-gamma2 gene.

    Stefan N, Fritsche A, Häring H, Stumvoll M.

    Diabetes. 2001 May;50(5):1143-8.PMID: 11334419 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.

    Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O.

    Diabetologia. 2001 Sep;44(9):1170-6.PMID: 11596673 [PubMed - indexed for MEDLINE]Related articles

    10.

    Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.

    Niskanen L, Lindi V, Erkkilä A, Sivenius K, Luoma J, Ylä-Herttuala S, Laakso M, Uusitupa MI.

    Metabolism. 2003 Feb;52(2):213-7.PMID: 12601635 [PubMed - indexed for MEDLINE]Related articles

    11.

    Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women.

    Nicklas BJ, Ferrell RE, Rogus EM, Berman DM, Ryan AS, Dennis KE, Goldberg AP.

    Hum Genet. 2000 Apr;106(4):420-4.PMID: 10830909 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.

    Brisson D, Ledoux K, Bossé Y, St-Pierre J, Julien P, Perron P, Hudson TJ, Vohl MC, Gaudet D.

    Pharmacogenetics. 2002 Jun;12(4):313-20.PMID: 12042669 [PubMed - indexed for MEDLINE]Related articles

    13.

    Association of lipoprotein lipase gene polymorphisms with coronary artery disease.

    Anderson JL, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J, Mixson L, Carlquist JF.

    J Am Coll Cardiol. 1999 Mar 15;33(4):1013-20.PMID: 10091829 [PubMed - indexed for MEDLINE]Related articles

    14.

    Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden.

    Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE.

    Atherosclerosis. 1992 Dec;97(2-3):171-85.PMID: 1466662 [PubMed - indexed for MEDLINE]Related articles

    15.

    Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass.

    Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, Hunter DJ.

    Hum Mol Genet. 2003 Nov 15;12(22):2923-9. Epub 2003 Sep 23.PMID: 14506127 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.

    Chen Q, Razzaghi H, Demirci FY, Kamboh MI.

    Atherosclerosis. 2008 Sep;200(1):102-8. Epub 2008 Feb 1.PMID: 18242618 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.

    Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Iovine C, Masulli M, Colantuoni V, Riccardi G.

    Clin Endocrinol (Oxf). 2002 Oct;57(4):481-6.PMID: 12354130 [PubMed - indexed for MEDLINE]Related articles

    18.

    A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.

    Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H, Nakayama M, Kotani R, Yamada K, Sakata M, Kurohara M, Wiyono P, Asdie H, Sakaue M, Taniguchi H, Yokono K.

    Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):465-9.PMID: 15739197 [PubMed - indexed for MEDLINE]Related articles

    19.

    The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.

    Catalano M, Cortelazzo A, Santi R, Contino L, Demicheli M, Yilmaz Y, Zorzetto M, Campo I, Lanati N, Emanuele E.

    Clin Biochem. 2008 Aug;41(12):981-5. Epub 2008 May 27.PMID: 18538667 [PubMed - indexed for MEDLINE]Related articles

    20.

    Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.

    Radha V, Vimaleswaran KS, Babu HN, Abate N, Chandalia M, Satija P, Grundy SM, Ghosh S, Majumder PP, Deepa R, Rao SM, Mohan V.

    Diabetes Care. 2006 May;29(5):1046-51.PMID: 16644635 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity